Neuland is manufacturer of Active Pharmaceutical Ingredients and provider of Contract Research Services. Neluand has been Preferred Source world wide for APIs and Intermediates for over 25 years. Neluand has 2 manufacturing plants which have been thrice each successfully inspected by USFDA. Their facilities have also been successfully inspected by German Health Authority and EDQM. Neluand has a R&D Centre which houses 130 scientists engaged in NCE custom synthesis work. The custom synthesis is complemented by 2 cGMP Kilo Labs, 1 non-GMP Kilo Lab and cGMP Pilot Plant. Neluand offer custom synthesis and manufacturing services to the Pharmaceutical industry. Neuland latest foray is in Generic peptide synthesis and we are currently offering Building Blocks to the market.
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's Humulin® R U-500 KwikPen®(insulin human injection) 500 units/mL, a pre-filled device containing Humulin R U-500, a highly concentrated formulation of insulin. Humulin R U-500 is the only FDA-approved insulin that is five-times more concentrated than standard U-100 insulin. This insulin is used to treat high blood sugar in people with type 1 and type 2 diabetes who need more than 200 units of insulin per day. The safety and efficacy of Humulin R U-500 used in combination with other insulins or delivered by an insulin infusion pump has not been determined.
.png)
